Adrenaline Nasal Pack vs Xylometazoline Nasal Drops During Nasotracheal Intubation
Trial statusRecruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18-60
SponsorShaheed Mohtarma Benazir Bhutto Institue of Trauma
About this trial
The goal of this trial is to compare efficacy of xylometazoline nasal drops and adrenaline nasal pack in participants undergoing elective oromaxillofacial surgeries.
The main question aim to answer is xylometazoline nasal drops better than adrenaline nasal packing in terms of nasal bleeding during nasotracheal intubation. Researchers are comparing 2 groups of participants.
Participants in group Xylometazoline are receiving 0.1% xylometaxoline nasal drops.
Participants in group Adrenaline are receiving adrenaline nasal packing.
Eligibility criteria
Qualifiers
ASA 1 and 2
Age group between 18-60 years
Mallampati score 1 and 2
Either gender
Disqualifiers
Lack of consent
Participants with anticipated difficult airway
Participants receiving anticoagulant therapy
History of nasal abnormality (nasal surgery, trauma, polyp, obstruction)
Trial design
Treatments tested in this trial
- 0.1% xylometazoline nasal drops
- Adrenaline nasal pack
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov